Drug
Lumacaftor
Lumacaftor: highest development phase Phase 1, developed by Vertex Pharmaceuticals. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Vertex Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| lumacaftor NCT01899105 | Phase 1 | Cystic Fibrosis |
Latest
No recent events.
Follow Lumacaftor on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.